购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-93 (Compound 9) 是一种针对羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的抑制剂,其IC50值介于 0.1 μM 和 0.5 μM 之间。该化合物主要用于研究肝病、代谢性疾病或心血管疾病,包括非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪肝炎 (NASH) 或药物性肝损伤 (DILI)。
HSD17B13-IN-93 (Compound 9) 是一种针对羟基类固醇 17β-脱氢酶 13 (HSD17B13) 的抑制剂,其IC50值介于 0.1 μM 和 0.5 μM 之间。该化合物主要用于研究肝病、代谢性疾病或心血管疾病,包括非酒精性脂肪肝病 (NAFLD)、非酒精性脂肪肝炎 (NASH) 或药物性肝损伤 (DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-93 (Compound 9) acts as an inhibitor targeting hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibiting an IC 50 for estradiol ranging between greater than 0.1 μM and up to 0.5 μM. Its application extends to the study of liver, metabolic, and cardiovascular diseases including NAFLD and NASH, alongside drug-induced liver injury (DILI) [1]. |
分子量 | 473.83 |
分子式 | C19H12ClF4N3O3S |
CAS No. | 2848620-87-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容